GeriQBank · Paper III · Q9
Thrombocytopenia
- Chapter
- Haematology
- Years asked
- Not recorded in the source
- Frequency
- Set 1× in Paper III (2009–2025)
As set in the university paper
What are the mechanisms of drug-induced thrombocytopenia?
Paper III · Haematology & Oncology · asked ×1 · 7-mark note · see in paper list
Linked automatically by wording similarity — check that this answer matches the question as set.
Detailed answer
Pro · free in betaAttempt it firstOutline your answer as a 7-mark note before revealing it — definition, causes, evaluation, management and the geriatric angle.Reveal answer
Well covered: Pathy's Ch. 24 ("Disorders of Platelet Number"), supplemented by Ch. 23 (DIC).
High-Yield Points
Definition: platelet count <1,50,000/µL. Platelet count does NOT change with normal ageing — a low count always signifies disease.
Haemostasis normal above 80,000/µL. Spontaneous haemorrhage (incl. ICH) doesn't occur until <20,000/ µL.
Three mechanisms: decreased production, increased destruction (consumption/immune), splenic pooling. Always consider drugs as a cause.
Immune Thrombocytopenia (ITP)
Adult ITP: insidious onset, chronic course (unlike childhood ITP which is acute, post-viral, self-limiting).
Autoantibody against GPIb/GPIIb-IIIa; platelet survival falls from 7–10 days to hours.
Always repeat count + check film first to exclude pseudothrombocytopenia (EDTA-clumping/clotted sample).
Treatment ladder: prednisolone 1mg/kg or IVIg 1g/kg×2 days (first line) → TPO-RAs/romiplostim/eltrombopag (second line) → splenectomy (third line, needs pre-op vaccination) → azathioprine/cyclophosphamide (last resort).
Drug-Induced & Other Causes
Two mechanisms: direct marrow suppression, or immune-mediated. Common culprits: aspirin, paracetamol, antibiotics, anticonvulsants, diuretics, quinine, quinidine.
HIT is the exception — causes THROMBOSIS not bleeding. Mortality ~30% if untreated. Treatment: stop heparin, start argatroban (acute) then fondaparinux. Warfarin worsens acute HIT.
DIC vs TTP
Test DIC TTP
Coagulation screen Grossly abnormal Normal/mild
Fibrinogen Low (<100 mg/dL) Normal
D-dimer >1000 ng/mL Normal/mild ↑
Key feature Multi-organ failure from microthrombosis Pentad: fever, thrombocytopenia, neuro, renal, MAHA Treatment Treat cause + product support Plasma exchange + steroids/rituximab Two Geriatric Pearls
In MDS, platelet dysfunction coexists with thrombocytopenia — bleeding/infection are commonest causes of death.
In myeloproliferative disorders, bleeding is paradoxically MORE common at very high platelet counts (>10,00,000/µL).
Latest Updates (2023–Present)
Rilzabrutinib (oral BTK inhibitor) — FDA-approved Aug 2025 for persistent/chronic ITP; dual mechanism (blocks autoantibody production AND FcγR-mediated platelet phagocytosis) — LUNA3 trial. Splenectomy moved far down the ladder — ASH now recommends TPO-RAs/rituximab first; delay splenectomy ≥12 months. ITP renamed "immune thrombocytopenia", threshold now <1,00,000/µL. TTP: ISTH 2025 update — recombinant ADAMTS13 (apadamtase alfa) now preferred over FFP in congenital TTP; caplacizumab confirmed standard in immune TTP alongside plasma exchange. HIT now part of a family of "anti-PF4 disorders" (autoimmune HIT, spontaneous HIT, VITT); DOACs now accepted alternatives to argatroban/fondaparinux in stable HIT.
Current Practice Update
Domain Pathy's (2022) Current evidence
ITP later Splenectomy, then Splenectomy deferred ≥12 months; rilzabrutinib (2025) major new MD Geriatrics – Haematology Compendium Page 19 of 34 lines azathioprine/cyclophosphamide option HIT Classic heparin-triggered; Part of anti-PF4 spectrum including VITT; DOACs accepted argatroban→fondaparinux TTP Plasma exchange + steroids/rituximab Adds caplacizumab; recombinant ADAMTS13 first choice in congenital TTP MD Geriatrics – Haematology Compendium Page 20 of 34
How was your recall?
Rating marks the question complete. “Need another pass” also adds it to your bookmarks.
References
- PAPERS-2-3-4_COMBINED.pdf — page 858
- GeriQBank source PDF — p. 858
Spotted an error or something out of date?Report a problem with this page